Background Atrial fibrillation (AF) is the most common sustained arrhythmia in adults, associated with significant morbidity, mortality, and economic burden due to thromboembolic events.
Tomás Abbot +5 more
doaj +1 more source
Real-world bleeding risk and molecular interaction profiles of direct oral anticoagulants: a comparative study integrating clinical outcomes and <i>in silico</i> docking. [PDF]
Onar LC, Guner E, Yilmaz I.
europepmc +1 more source
Modulatory Effects of Dabigatran on PAR-1 Activity and Viability in Adipose-Derived Mesenchymal Stem Cells. [PDF]
Kubat E, Gürpınar ÖA, Özdem T.
europepmc +1 more source
Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agents. [PDF]
El-Masri S +12 more
europepmc +1 more source
Inhibition of adenosine kinase alleviates hypertrophic cardiomyopathy by ameliorating coronary microvascular dysfunction. [PDF]
Wan F +7 more
europepmc +1 more source
The novel anticoagulant dabigatran versus enoxaparin for thromboprophylaxis following total hip replacement: a meta-analysis. [PDF]
Huang J, Ye J.
europepmc +1 more source
Intravenous thrombolysis for acute cerebral embolism during atrial fibrillation ablation: a case report and systematic review with meta-analysis. [PDF]
Cai B +5 more
europepmc +1 more source
Dabigatran Reversal with Idarucizumab
Pollack, Charles V. +2 more
openaire +6 more sources

